Importantly, using a specific neutralizing antibody to abolish the effects of HMGB1 in exosomes from ESCC efficiently inhibited PD1+ TAM expansion (Fig. 4d–j). The gene discussed is PDCD1; the disease is esophageal squamous cell carcinoma.